Related Experiment Videos
Immunosuppression in organ transplantation
1Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Japanese Journal of Pharmacology
|June 1, 1996
Summary
Organ transplantation faces immunological barriers. Modern immunosuppressive drugs target specific immune cells, but combinations are needed to balance efficacy and minimize toxicity.
Area of Science:
- Transplantation Immunology
- Pharmacology
Background:
- The immunological barrier is a primary challenge in organ transplantation.
- Early advancements include corticosteroids, ciclosporin, azathioprine, and FK506, revolutionizing the field.
- Current research focuses on targeted immunosuppression to spare host resistance.
Purpose of the Study:
- To review the landscape of immunosuppressive therapies in organ transplantation.
- To highlight the evolution and mechanisms of immunosuppressive agents.
- To emphasize the necessity of combination therapy for optimal outcomes.
Main Methods:
- Literature review of immunosuppressive therapies in organ transplantation.
- Categorization of immunosuppressive strategies into chemical, biological, physical, and surgical.
- Analysis of the mechanisms of action for key immunosuppressive drugs.
Main Results:
- Chemical immunosuppressants remain central to organ transplantation.
- Newer agents selectively target T and B cells, inhibiting cytokine pathways or cell differentiation.
- No single agent provides a complete solution; combination therapies are standard.
Conclusions:
- Effective immunosuppression requires a combination of agents with distinct mechanisms.
- Balancing therapeutic efficacy with minimal host toxicity is crucial.
- Continued research into targeted immunosuppression is vital for advancing transplantation.